What Cronos Group Inc.’s (TSX:CRON) Earnings Mean for Cannabis Stocks

Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) released some less than exciting news in its latest report, but what does that mean for other cannabis stocks?

| More on:

If you’ve been plugging your ears against the noise that is the cannabis industry this week, then you may not have heard about the latest fourth-quarter earnings report getting analysts going.

Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) announced a net loss on March 26, due to an increase in operating costs, missing analysts’ estimates. The loss wasn’t small either, with the company losing $11.6 million, compared to a profit of $2.1 million this same time last year.

But while this loss is important, it wasn’t the only thing being reported by the company. Cronos also told investors about its huge increase in sales after legalization. The company saw revenue more than triple to $5.6 million since the last earnings report on December 31.

So what does this mean for other cannabis companies? And where does Cronos stand among them?

Cronos’ big break

While Cronos may be smaller than a lot of cannabis companies out there, it’s still in the same position of growing its production and expanding into international markets, most notably the U.S.

The company inked a deal with Altria Group Inc. late last year that had investors thrilled at the news. The Marlboro cigarette maker would hold a 45% stake in the company after acquiring it for $2.4 billion, with the option to boost that stake to 55% should the company prove worthy.

The deal would be a huge help to the cannabis company in expanding throughout the U.S. market, and in the short term its certainly helped as well. Cronos used some of that cash to fully pay off its credit with Canadian Imperial Bank of Commerce and Bank of Montreal.

Cronos also announced its acquisition of NatuEra in Colombia to expand its greenhouse capacity, though plans aren’t available yet. And that’s where Cronos has a problem.

Cronos currently has a growth capacity of about 40,000 kilograms of cannabis per year. It has a joint venture to increase this capacity to about 70,000 kilograms called Cronos GrowCo, but that won’t be available until 2020. This puts Cronos near the bottom of some of its bigger peers in terms of production. With legalization now in the rearview, Cronos may struggle to reach those same sales numbers.

Peer pressure

Cronos is certainly getting pressure to perform next to its peers. As I mentioned, the stock is near the bottom in terms of what it can produce. Aurora Cannabis Inc.Canopy Growth Corp., and Aphria Inc. are all already in the triple digits when it comes to kilograms produced per year. So Cronos has a lot of catching up to do.

It also has a lot of catching up in the revenue department, despite announcing a 248% increase. Canopy Growth reported revenue of $83 million last quarter, and Aurora $54 million. And, oh yeah, Aurora’s stock is also way cheaper, so there’s that going for it as well.

Bottom line

While it wasn’t the best news for Cronos, it wasn’t all that bad for the cannabis industry as a whole. Granted, Cronos is going through the same growing pains as everyone else. Canopy is reinvesting so much back into its business, it probably will be posting a loss soon too.

But the difference is that Cronos is so much smaller, and those growing pains are going to hurt for a while before it finally reaches peak production.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis and Canopy Growth.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »